Submit Deal

HUTCHISON CHINA MEDITECH LIMITED

Deals Overview

Total Deals5

Valued Deals5

Total Value£ 432 M

Avg. Deal Size£ 86 M

Market Context

Senior Management

Christian Hogg
CEO
Johnny Cheng
CFO
Mark Lee
Senior Vice President

Sort

25 Jun 2020|Hong Kong|Pharmaceuticals

Target: HUTCHISON CHINA MEDITECH LIMITED

Bidder: GENERAL ATLANTIC LLC

6 Service Providers

5 Target | 1 Bidder

10 Dealmakers

8 Target | 2 Bidder

£ 80 M

Value

17 Nov 2020|Hong Kong|Pharmaceuticals

Target: HUTCHISON CHINA MEDITECH LIMITED

Bidder: CANADA PENSION PLAN INVESTMENT BOARD

7 Service Providers

5 Target | 2 Bidder

13 Dealmakers

10 Target | 3 Bidder

£ 75 M

Value

17 Nov 2020|Hong Kong|Pharmaceuticals

Target: HUTCHISON CHINA MEDITECH LIMITED

Bidder: CANADA PENSION PLAN INVESTMENT BOARD

6 Service Providers

5 Target | 1 Bidder

19 Dealmakers

14 Target | 5 Bidder

£ 75 M

Value

08 Apr 2021|Hong Kong|Pharmaceuticals

Target: HUTCHISON CHINA MEDITECH LIMITED

Bidder: BPEA EQT

9 Service Providers

6 Target | 3 Bidder

16 Dealmakers

11 Target | 5 Bidder

£ 72 M

Value

24 Mar 2021|China|Pharmaceuticals

Target: HUTCHISON WHAMPOA GUANGZHOU BAIYUNSHAN CHINESE MEDICINE COMPANY

Bidder: GL CAPITAL GROUP

6 Service Providers

1 Bidder | 5 Vendor

13 Dealmakers

1 Bidder | 12 Vendor

£ 127 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy